{
    "clinical_study": {
        "@rank": "30212", 
        "arm_group": {
            "arm_group_label": "CF patients", 
            "description": "Both children and adults, with or without vitamin D deficiency."
        }, 
        "biospec_descr": {
            "textblock": "plasma"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The investigators study is designed to test the hypothesis that correction of vitamin D in\n      CF patients can increase their lung function and decrease the number of their pulmonary\n      exacerbations."
        }, 
        "brief_title": "The Effect of Vitamin D on Lung Function in Patients With Cystic Fibrosis", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Vitamin D deficiency is a known problem in CF patients.  The CF Foundation Committee\n      published in April 2012 new guidelines for administering vitamin D in CF patients.  The\n      investigators' study is designed to look for association between normal serum vitamin D\n      levels and lung function.  ~100 CF patients from The Center of Chronic Diseases in Hadassah\n      Medical Organization will be treated according to the new guidelines, and their lung\n      function will be tested once a month during the trial, which will be held for at least one\n      year.  In this study, the investigators' goal is to test the efficiency of the new\n      guidelines in correcting serum vitamin D levels, and to follow other related factors such as\n      growth indices (height, weight, BMI), bone mineral density, number of pulmonary\n      exacerbations and number of hospital admissions."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical and laboratory diagnosis of Cystic Fibrosis\n\n        Exclusion Criteria:\n\n          -  Age under 4 years old (because of the inability to assess lung function in a reliable\n             fashion)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "4 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "CF patients (both children and adults) from The Center for Chronic Diseases in Hadassah\n        Medical Organization."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02043717", 
            "org_study_id": "vitaminD-HMO-CTIL"
        }, 
        "intervention": {
            "arm_group_label": "CF patients", 
            "description": "According to the new guidelines by:\nTangpricha V, Kelly a, Stephenson a, Maguiness K, Enders J, Robinson K a, et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. The Journal of clinical endocrinology and metabolism [Internet]. 2012 May [cited 2012 Oct 31];97(4):1082-93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22399505", 
            "intervention_name": "Vitamin D", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cystic Fibrosis", 
            "Vitamin D", 
            "Lung function"
        ], 
        "lastchanged_date": "January 21, 2014", 
        "location": {
            "contact": {
                "email": "michaelwil@hadassah.org.il", 
                "last_name": "Michael Wilschanski, Prof.", 
                "phone": "00 9722-5845039"
            }, 
            "contact_backup": {
                "email": "lhadas@hadassah.org.il", 
                "last_name": "Hadas Lemberg, PhD", 
                "phone": "00 972 2 6777572"
            }, 
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel"
                }, 
                "name": "Hadassah Medical Organization"
            }, 
            "investigator": [
                {
                    "last_name": "Michael Wilschanski, Prof.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Yasmeen Abu-Fraiha, B.Med.Sci", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Effect of Vitamin D on Lung Function in Patients With Cystic Fibrosis", 
        "other_outcome": {
            "description": "To assess correction efficiency and hypervitaminosis D", 
            "measure": "Vitamin D level", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline, and then, on average, once a month during trial (at least one year)."
        }, 
        "overall_contact": {
            "email": "michaelwil@hadassah.org.il", 
            "last_name": "Michael Wilschanski, Prof.", 
            "phone": "00 9722-5845039"
        }, 
        "overall_contact_backup": {
            "email": "lhadas@hadassah.org.il", 
            "last_name": "Hadas Lemberg, PhD", 
            "phone": "00 972 2 6777572"
        }, 
        "overall_official": {
            "affiliation": "Hadassah Medical Organization", 
            "last_name": "Michael Wilschanski, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "FEV1 (by % of predicted)", 
            "safety_issue": "No", 
            "time_frame": "Baseline, and then, on average, once a month during trial (at least one year)."
        }, 
        "reference": [
            {
                "PMID": "22399505", 
                "citation": "Tangpricha V, Kelly A, Stephenson A, Maguiness K, Enders J, Robinson KA, Marshall BC, Borowitz D; Cystic Fibrosis Foundation Vitamin D Evidence-Based Review Committee. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab. 2012 Apr;97(4):1082-93. doi: 10.1210/jc.2011-3050. Epub 2012 Mar 7."
            }, 
            {
                "PMID": "18589445", 
                "citation": "Green D, Carson K, Leonard A, Davis JE, Rosenstein B, Zeitlin P, Mogayzel P Jr. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. J Pediatr. 2008 Oct;153(4):554-9. Epub 2008 Jun 27."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02043717"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "pulmonary exacerbations", 
                "safety_issue": "No", 
                "time_frame": "number in a year"
            }, 
            {
                "measure": "Hospital admissions", 
                "safety_issue": "No", 
                "time_frame": "number in a year"
            }
        ], 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "January 2014"
    }
}